Filing Details

Accession Number:
0001415889-23-002956
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-21 19:05:11
Reporting Period:
2023-02-16
Accepted Time:
2023-02-21 19:05:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1159036 Halozyme Therapeutics Inc. HALO Biological Products, (No Disgnostic Substances) (2836) 880488686
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1507174 J. Michael Labarre C/O Halozyme Therapeutics, Inc.
12390 El Camino Real
San Diego CA 92130
Svp, Chief Technical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-02-16 6,112 $0.00 151,805 No 4 M Direct
Common Stock Disposition 2023-02-16 2,878 $49.26 148,927 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2023-02-16 6,112 $0.00 6,112 $0.00
Common Stock Option to Purchase Common Stock Acquisiton 2023-02-16 48,849 $0.00 48,849 $49.26
Common Stock Restricted Stock Units Acquisiton 2023-02-16 17,053 $0.00 17,053 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,336 No 4 M Direct
48,849 2024-02-16 2033-02-16 No 4 A Direct
17,053 2024-02-16 No 4 A Direct
Footnotes
  1. The reported disposition of 2,878 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
  2. This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
  3. This option vests one-fourth on such date and then 1/48th monthly thereafter.
  4. This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.